Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Xtreme One Entertainment Announces iNDEMAND as Broadcast Partner for XFC 50
-
Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart
-
Annovis Bio Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial Results
-
AIM ImmunoTech Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
-
HydroGraph Announces AGM Update
-
Verrica Pharmaceuticals Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
-
Revive Therapeutics Provides Update on Psilocybin Clinical Study for Methamphetamine Use Disorder
-
Phio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business Update
-
Lilium Begins Integration of Garmin Standby Flight Instruments for the Lilium Jet
-
Nominations Open for Canadian Safety Achievement Awards
-
Scandinavian Tobacco Group A/S: Transactions in connection with share buy-back programme
-
FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM
-
Arch Biopartners Adds Three New Clinical Sites into the Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury
-
Coda Octopus Group Reports that its Echoscope® Technology used as the Primary Survey Tool in the Francis Scott Key Bridge ongoing salvage operations.
-
Block listing Interim Review
-
Invesco Ltd: Form 8.3 - Mondi PLC
-
FTAI Aviation Commences Cash Tender Offer for Any and All of Its Outstanding 6.50% Senior Notes Due 2025
-
The Ritz-Carlton Residences, The Woodlands Reports Record-Breaking Sales of Over $250 Million in Opening Week
-
Asante Announces Filing of Meeting Materials for Annual General Meeting of Shareholders
-
Traws Pharma Announces New Employee Inducement Grants
-
Total voting rights
-
Man Group PLC : Form 8.3 - International Paper Company
-
Invesco Ltd: Form 8.3 - Mondi plc
-
EnviroGold Global Announces Webinar to be held on April 9, 2024, led by CEO David Cam and CTO Brock Hill
-
Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
-
US Army Awards $12 Million Contract Extension to Gilat to Sustain Anytime, Anywhere Satellite Connectivity
-
Hexiris Welcomes Dr. Paul Harasymowycz to Its Scientific Committee
-
HPH Announces Change of Independent Auditor
-
David Higley Joins Perella Weinberg as Partner
-
Anfield Energy Welcomes Doug Beahm as Chief Operating Officer to Spearhead the Advancement of its U.S. Uranium Production Projects
-
Helium Evolution Confirms Additional Drilling of Up to 9 New Wells on Joint Land and Provides Operations Update
-
Sable Provides 2023-2024 Field Season Exploration Update for Don Julio Project in San Juan, Argentina
-
Nurix Therapeutics Announces Extension of Strategic Collaboration with Gilead Sciences
-
Tacos by the Slice! Taco John's Introduces a Flavor Fiesta with Made-to-Order Taco Pizza, Available Now for a Limited Time
-
EyePoint Pharmaceuticals Expands Scientific Advisory Board with World-Renowned Retina Specialists
-
Bio-Path Holdings Provides 2024 Clinical and Operational Update
-
Plymouth Industrial REIT Provides Activity Update for First Quarter 2024
-
Talisker Intersects 38.17 g/t Au over 5.20 Metres from the Bralorne Gold Project Resource Conversion Program
-
Sandy Spring Bancorp, Inc. to Webcast First Quarter Earnings Conference Call on April 23, 2024
-
Presenting on the Emerging Growth Conference 69 Day 1 on April 3 Register Now
-
Indegene Hosts Inaugural Strategic Advisory Board Meeting Chaired By Renowned Global Biopharma Leader Jill DeSimone
-
Autolus Therapeutics announces acceptance of Marketing Authorization Application (MAA) by the European Medicines Agency (EMA) for obecabtagene autoleucel (obe-cel) for Patients with Relapsed/refractor
-
Tacos by the Slice! Taco John's Introduces a Flavor Fiesta with Made-to-Order Taco Pizza, Available Now for a Limited Time
-
Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Announce Business Combination to Form Traws Pharma, Inc, a Best-in-Class Virology and Oncology Company
-
Roivant Announces Positive NEPTUNE Study Results for Brepocitinib in NIU, as well as Board Authorization for up to $1.5 Billion Share Repurchase Program, Including Repurchase of Entire Sumitomo Pharma
-
Verve Therapeutics Announces Updates on its PCSK9 Program
-
TScan Therapeutics Announces Upcoming Presentation at the 23rd Annual Needham Virtual Healthcare Conference
-
Sweetwater Brewing Unveils New 420 Variety Pack
-
Connections Wellness Group first outpatient mental health provider to offer Cognia-accredited private school education at no cost to all its patients
-
Chemomab to Host Virtual Key Opinion Leader Webinar on Primary Sclerosing Cholangitis on April 10, 2024
